What Oxford Expression Technologies say about themselves
“Oxford Expression Technologies Ltd: UK-based leaders in the global pharmaceutical and biotechnology industries for baculovirus protein expression.”
“Oxford Expression Technologies Ltd: UK-based leaders in the global pharmaceutical and biotechnology industries for baculovirus protein expression.”
Officer details are public data from the Companies House register.
People and entities with significant control, from the Companies House PSC register
Companies where Oxford Expression Technologies Limited is registered as a person with significant control
Balance sheet as at 31 October 2025 · total exemption full accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £839,699 | £113,068 | £120,500 | £93,382 | £74,503 | £67,292 |
| Current Assets | £2,208,098 | £2,835,640 | £1,979,893 | £2,068,719 | £1,786,350 | £936,030 |
| Cash | £1,701,088 | £2,009,061 | £1,774,025 | £1,807,540 | £1,397,808 | £619,754 |
| Creditors (< 1 year) | £186,610 | £316,576 | £50,318 | £100,638 | £110,716 | £86,392 |
| Net Current Assets | £2,021,488 | £2,519,064 | £1,929,575 | £1,968,081 | £1,675,634 | £849,638 |
| Net Assets | £2,764,907 | £2,607,761 | £2,019,950 | £2,038,611 | £1,731,511 | £905,647 |
| Shareholder Funds | £2,764,907 | £2,607,761 | £2,019,950 | £2,038,611 | £1,731,511 | £905,647 |
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 7 April 2026 | Total exemption full accounts | 31 October 2025 | ||
| 18 February 2026 | Confirmation statement with updates | 16 February 2026 | ||
| 17 February 2026 | Director's details changed | |||
| 17 February 2026 | Change of details for a person with significant control | |||
| 5 September 2025 | Purchase of own shares |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →